Likewise, in breast cancer, cell proliferation, migration, and tumor growth are enhanced via CLDN4-adhesion signaling, which works through interacting with LXRβ by targeting the AKT phosphorylation site S432 in LXRβ [87]. Here, NR1H2 is linked to neoplasm.